Page last updated: 2024-12-08

allose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID439507
CHEMBL ID1222152
CHEBI ID4093
CHEBI ID37690
CHEBI ID17393
CHEBI ID37742
SCHEMBL ID60362
MeSH IDM0042519

Synonyms (28)

Synonym
CHEMBL1222152
ALL ,
CHEBI:4093 ,
ALLOSE ,
C01487
d-allose ,
allose, d-
579-36-2
nsc-144657
d-allopyranose ,
DB03989
BMSE000008
AKOS006272674
BMSE000808
BMSE001008
SCHEMBL60362
d-all
allopyranose
d-allopyranoside
allopyranoside
Q27106301
DTXSID201015878
d-allo-hexose
dtxcid501474033
chebi:37690
allo-hexose
chebi:17393
chebi:37742

Research Excerpts

Overview

D-Allose is an aldohexose of the C3-epimer of d-glucose, existing in very small amounts in nature. D‑allose is a rare sugar which has been shown to have growth inhibitory effects in several kinds of malignancies.

ExcerptReferenceRelevance
"D-allose is a rare sugar that has been reported to up-regulate thioredoxin-interacting protein (TXNIP) expression and affect the production of intracellular reactive oxygen species (ROS). "( Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Akimitsu, K; Haba, R; Ibuki, E; Izumori, K; Kakehi, Y; Matsuoka, Y; Sugimoto, M; Taoka, R; Tohi, Y; Yoshihara, A; Zhang, X, 2022
)
1.69
"D-Allose is a rare cis-caprose with a wide range of physiological functions, which has a wide range of applications in medicine, food, and other industries. "( A study of targeted mutation of l-rhamnose isomerase to improve the conversion efficiency of D-allose.
Chen, Y; Dong, S; Duan, S; Li, Z; Ma, C; Wang, G; Wang, R; Wang, Y; Wu, Y, 2023
)
1.85
"d-Allose is an aldohexose of the C3-epimer of d-glucose, existing in very small amounts in nature, called a rare sugar. "( X-ray structures of Enterobacter cloacae allose-binding protein in complexes with monosaccharides demonstrate its unique recognition mechanism for high affinity to allose.
Kamitori, S, 2023
)
1.9
"d-Allose is a low-calorie rare sugar with great application potential in the food and pharmaceutical industries. "( Enhanced Thermostability of an l-Rhamnose Isomerase for d-Allose Synthesis by Computation-Based Rational Redesign of Flexible Regions.
Gao, X; Guan, L; Li, C; Liu, W; Lu, F; Qin, HM; Wang, F; Wang, J; Wei, M; Zhang, W, 2023
)
1.88
"d-Allose is a rare sugar that has been reported to have some unique physiological effects."( Radiosynthesis of
Ibaraki, M; Kinoshita, T; Kudomi, N; Nishiyama, Y; Tago, T; Toyohara, J; Wada, K; Yamamoto, H; Yamamoto, Y, 2019
)
1.07
"D-Allose is a rare sugar, can be used as an ingredient in a range of foods and dietary supplements, has alimentary activities, especially excellent anti-cancer effects and used in assisting cancer chemotherapy and radiotherapy, etc. "( Production of D-allose from D-fructose using immobilized L-rhamnose isomerase and D-psicose 3-epimerase.
Du, K; Gao, L; Li, C; Lin, H; Lin, J; Ren, Y, 2020
)
1.63
"D‑allose is a rare sugar which has been shown to have growth inhibitory effects in several kinds of malignancies. "( Additive antitumour effect of D‑allose in combination with cisplatin in non-small cell lung cancer cells.
Hossain, A; Kadowaki, N; Kamitori, K; Kanaji, N; Katagi, A; Noguchi, C; Tokuda, M, 2018
)
1.49
"D-Allose is a rare monosaccharide, which rarely appears in the natural environment. "( Recent research on the physiological functions, applications, and biotechnological production of D-allose.
Chen, J; Chen, Z; Guang, C; Mu, W; Zhang, T; Zhang, W, 2018
)
1.42
"D-allose is a monosaccharide. "( D-allose protects against endotoxemic acute renal injury.
Asaga, T; Chujo, K; Iwanaga, Y; Ono, J; Taie, S; Ueki, M, 2008
)
1.79
"D-Allose is a monosaccharide (C-3 epimer of glucose) distributed rarely in nature; because of its scarcity and cost, the biological effect has hardly been studied."( Rare sugar D-allose induces programmed cell death in hormone refractory prostate cancer cells.
Chung, BC; Jo, MJ; Kim, MO; Kim, SH; Lee, HY; Naha, N, 2008
)
1.27
"d-Allose is a novel anti-tumor monosaccharide that causes cell growth inhibition, specifically of the cancer cells, by inducing the tumor suppressor gene thioredoxin interacting protein (TXNIP). "( Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
Dong, Y; Horii, M; Kamitori, K; Sanada, K; Sui, L; Tokuda, M; Yamaguchi, F, 2008
)
1.44
"D-allose is an aldo-hexose present in nature that recently has been demonstrated to inhibit production of inflammatory mediators in septic kidneys."( D-allose ameliorates cisplatin-induced nephrotoxicity in mice.
Asaga, T; Miyawaki, Y; Shirakami, G; Tokuda, M; Ueki, M; Ueno, M, 2012
)
1.61
"D-allose is a rare sugar found in nature and, because of its very limited amount and of the high cost associated with its synthesis, its physiological functions remain virtually unknown. "( Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
Dong, Y; Hatano, N; Izumori, K; Sui, L; Tokuda, M; Watanabe, Y; Yamaguchi, F,
)
1.14

Effects

D-Allose has an 80% sweetness relative to table sugar but is ultra-low calorie and non-toxic. It is thus an ideal candidate to take the place of table sugar in food products.

D-allose has shown great promise for combating tumor cells with no side effects. Its potential for cancer therapy has not been comprehensively investigated. D-Allose has an 80% sweetness relative to table sugar but is ultra-low calorie and non-toxic.

ExcerptReferenceRelevance
"D-Allose has an 80% sweetness relative to table sugar but is ultra-low calorie and non-toxic and is thus an ideal candidate to take the place of table sugar in food products."( Recent research on the physiological functions, applications, and biotechnological production of D-allose.
Chen, J; Chen, Z; Guang, C; Mu, W; Zhang, T; Zhang, W, 2018
)
1.26
"D-allose has a considerable potential as a new anticancer agent in those patients."( Growth inhibition of head and neck carcinomas by D-allose.
Hoshikawa, H; Hosokawa, T; Kamitori, K; Mitani, T; Mori, N; Mori, T; Tokuda, M; Tsukamoto, I; Yamaguchi, F, 2009
)
1.16
"D-Allose has been demonstrated to exert many physiological functions."( Immunomodulatory effects of D-allose on cytokine production by plasmacytoid dendritic cells.
Akimitsu, K; Hoshino, K; Miyake, M; Miyazaki, R; Suzuki, M; Takao, K, 2022
)
1.57
"d-allose has the biological activity to protect against ischemia-reperfusion injury, however, the underlying mechanism remains unclear."( d-allose protects brain microvascular endothelial cells from hypoxic/reoxygenated injury by inhibiting endoplasmic reticulum stress.
Fei, Z; Fu, YH; Gao, DK; Gou, MR; Luo, YW; Zhang, L; Zhang, M, 2023
)
2.19
"D-allose has shown great promise for combating tumor cells with no side effects, especially in combination with first-line drugs; however, its potential for cancer therapy has not been comprehensively investigated in vitro or in vivo."( D-allose: Molecular Pathways and Therapeutic Capacity in Cancer.
Ganjavi, M; Khajeh, S; Panahi, G; Razban, V; Tahami, SM; Zare, M, 2023
)
2.35
"D-Allose has an 80% sweetness relative to table sugar but is ultra-low calorie and non-toxic and is thus an ideal candidate to take the place of table sugar in food products."( Recent research on the physiological functions, applications, and biotechnological production of D-allose.
Chen, J; Chen, Z; Guang, C; Mu, W; Zhang, T; Zhang, W, 2018
)
1.26
"As d-allose has no known side effects on normal cells, the combination of d-allose and 5-FU might be a potent candidate for cancer therapy."( Rare sugar D-allose enhances anti-tumor effect of 5-fluorouracil on the human hepatocellular carcinoma cell line HuH-7.
Dong, Y; Horii, M; Kamitori, K; Sanada, K; Sui, L; Tokuda, M; Yamaguchi, F, 2008
)
1.17
"D-allose has a considerable potential as a new anticancer agent in those patients."( Growth inhibition of head and neck carcinomas by D-allose.
Hoshikawa, H; Hosokawa, T; Kamitori, K; Mitani, T; Mori, N; Mori, T; Tokuda, M; Tsukamoto, I; Yamaguchi, F, 2009
)
1.16
"D-allose has attracted a great deal of attention in recent years due to its many pharmaceutical activities, which include anti-cancer, anti-tumor, anti-inflammatory, anti-oxidative, anti-hypertensive, cryoprotective, and immunosuppressant activities. "( Microbial metabolism and biotechnological production of D-allose.
Lim, YR; Oh, DK, 2011
)
1.33

Treatment

D-allose treatment significantly suppressed the MPO activity and the number of MPO-positive cells compared with those in the vehicle group. Co-treatment of D-allOSE and the antioxidant L-glutathione canceled the D- allose-induced reduction in cell viability and intracellular ROS elevation.

ExcerptReferenceRelevance
"D-allose treatment inhibited the proliferation of U251MG and U87MG cells in a dose-dependent manner (3-50 mM)."( Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma.
Akimitsu, K; Fujimori, T; Izumori, K; Kanda, T; Miyake, K; Nishiyama, A; Ogawa, D; Ohsaki, H; Rahman, A; Shibayama, Y; Suzuki, K; Tamiya, T; Ye, J, 2023
)
1.75
"D-allose treatment significantly suppressed the MPO activity and the number of MPO-positive cells compared with those in the vehicle group, suggesting that treatment with D-allose can reduce the infiltration of leukocytes into the ischemic tissue."( Anti-inflammatory effect of D-allose in cerebral ischemia/reperfusion injury in rats.
Fei, Z; Gao, D; Kawai, N; Lu, F; Nakamura, T; Tamiya, T, 2013
)
1.24
"D-allose treatment of isolated islet culture prior to transplantation restored islet function and increased successful transplant rate. "( Beneficial effect of D-allose for isolated islet culture prior to islet transplantation.
Akamoto, S; Asano, E; Hossain, A; Kashiwagi, H; Noguchi, C; Okano, K; Sui, L; Suzuki, Y; Tokuda, M, 2016
)
1.47
"D-allose-treated cells."( Evidence that modulation of glucose transporter intrinsic activity is the mechanism involved in the allose-mediated depression of hexose transport in mammalian cells.
Colby-Germinario, S; Germinario, RJ; Manuel, S; Pratt, SE, 1994
)
1.06
"Co-treatment of D-allose and the antioxidant L-glutathione canceled the D-allose-induced reduction in cell viability and intracellular ROS elevation."( Antitumor Effects of Orally Administered Rare Sugar D-Allose in Bladder Cancer.
Akimitsu, K; Haba, R; Ibuki, E; Izumori, K; Kakehi, Y; Matsuoka, Y; Sugimoto, M; Taoka, R; Tohi, Y; Yoshihara, A; Zhang, X, 2022
)
1.29
"Treatment of D-allose also significantly decreased the number of COX-2-positive cells and microglial activation in the ischemic tissue."( Anti-inflammatory effect of D-allose in cerebral ischemia/reperfusion injury in rats.
Fei, Z; Gao, D; Kawai, N; Lu, F; Nakamura, T; Tamiya, T, 2013
)
1.02

Toxicity

ExcerptReferenceRelevance
" These results suggest that D-allose is not toxic to rats."( Acute and sub-chronic toxicity of D-allose in rats.
Iga, Y; Matsuo, T; Nakamichi, K; Shirai, Y, 2010
)
0.92

Compound-Compound Interactions

ExcerptReferenceRelevance
" In combination with cisplatin, D‑allose had a synergistic growth inhibitory effect."( Additive antitumour effect of D‑allose in combination with cisplatin in non-small cell lung cancer cells.
Hossain, A; Kadowaki, N; Kamitori, K; Kanaji, N; Katagi, A; Noguchi, C; Tokuda, M, 2018
)
1.04

Dosage Studied

ExcerptRelevanceReference
" Although the mechanism is not clear, by using those sugars for treatment with metronidazole, the drug dosage could be lowered and the development of drug resistance of trichomonad parasites might be prevented."( D-allose and D-psicose reinforce the action of metronidazole on trichomonad.
Arai, M; Harada, M; Hayashi, H; Kondo, E; Suezawa, C; Suguri, S, 2012
)
1.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
D-allose
allopyranose
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
D-Allulose Degradation69
D-allose degradation38

Bioassays (1)

Assay IDTitleYearJournalArticle
AID500279Ratio of Kcat to Km for Neisseria meningitidis lgtC2006Nature chemical biology, Dec, Volume: 2, Issue:12
Using substrate engineering to harness enzymatic promiscuity and expand biological catalysis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (151)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (9.93)18.7374
1990's10 (6.62)18.2507
2000's42 (27.81)29.6817
2010's59 (39.07)24.3611
2020's25 (16.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.30 (24.57)
Research Supply Index5.04 (2.92)
Research Growth Index4.94 (4.65)
Search Engine Demand Index94.08 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (3.27%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other148 (96.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]